Physical stability studies of miscible amorphous solid dispersions

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 4005-4012

  Ivanisevic, Igor ^a  

^a Aptuit Inc   (United States)

Author keywords

Amorphous; Crystallization; Physical stability; Polymeric drug delivery systems; Solid dispersion; Stabilization; X ray powder diffractometry

Indexed keywords

FELODIPINE; INDOMETACIN; KETOCONAZOLE; NIFEDIPINE; POLYACRYLIC ACID; POVIDONE;

AMORPHOUS SOLID DISPERSION; ARTICLE; CRYSTALLIZATION; DISPERSION; DRUG FORMULATION; HUMIDITY; PHYSICAL PARAMETERS; SOLUBILITY; X RAY POWDER DIFFRACTION;

EID: 77956361796     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22247     Document Type: Article

References (27)

1. Hancock BC. 2002. Disordered drug delivery: Destiny, dynamics and the deborah number. J Pharm Pharmacol 54:737-746.
2. Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47-60. (Pubitemid 30326688)
3. Craig DQM. 2002. The mechanism of drug release from solid dispersions in water soluble polymers. Int J Pharm 231:131-144.
4. Yalkowsky SH. 1999. Solubility and solubilization in aqueous media. 1st edition. Oxford: Oxford University Press.
5. Grant DJW, Higuchi T. 1990. Solubility behavior of organic compounds. 1st edition. New York, NY: John Wiley & Sons.
6. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86.
7. Serajuddin ATM. 1999. Solid dispersion of poorly water soluble drugs: Early promises, subsequent problems, and recent break-throughs. J Pharm Sci 88:1058-1066.
8. Shamblin SL, Taylor LS, Zografi G. 1998. Mixing behavior of colyophilized binary amorphous systems. J Pharm Sci 87:694-701. (Pubitemid 28268567)
9. Lodge TP, Wood ER, Haley JC. 2006. Two glass transitions do not necessarily indicate immiscibiity: The case of PEO/PMMA. J Polym Scir B, Polym Phys 44:756-763.
10. Krause S, Iskander M. 1977. Phase separation in styrene-amethyl styrene block copolymers. In Polymer Science and Technology. D. Klempner, & K.C. Frisch, Eds. New York: Plenum Press, Vol. 10: pp. 231-243.
11. Newman A, Engers D, Bates S, Ivanisevic I, Kelly R, Zografi G. 2008. Characterization of API:polymer mixtures using X-ray powder diffraction. J Pharm Sci 97:4840.
12. Rumondor ACF, Marsac PJ, Stanford L, Taylor LS. 2009. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol Pharm 6:1492-1505.
13. Marsac PJ, Rumondor ACF, Nivens DE, Kestur US, Stanciu L, Taylor LS. 2009. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(-vinylpyrrolidone). J Pharm Sci 99:169-185.
14. Ivanisevic I, Bates S, Chen P. 2009. A novel method for the assessment of miscibility in amorphous dispersions. J Pharm Sci 98:3373-3386.
15. Rumondor ACF, Ivanisevic I, Bates S, Alonzo DE, Taylor LS. 2009. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res 26:2523-2534.
16. Marsac PJ, Li T, Taylor LS. 2009. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res 26:139-151.
17. Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R. 2001. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci 12:261-269.
18. Chiou WL, Riegelman S. 1969. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J Pharm Sci 58:1505-1510.
19. Taylor LS, Zografi G. 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 14:1691-1698. (Pubitemid 28062912)
20. Aso Y, Yoshioka S, Kojima S. 2003. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. J Pharm Sci 93:384-391.
21. Marsac PJ, Konno H, Taylor LS. 2006. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm Res 23:2306-2316.
22. Matsumoto T, Zografi G. 1999. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res 16:1722-1728. (Pubitemid 29530405)
23. Yang J, Grey K, Doney J. 2010. An improved kinetics approach to describe the physical stability of amorphous solid dispersions. Int J Pharm 384:24-31.
24. Ivanisevic I, Bugay DE, Bates S. 2005. On pattern matching of X-ray powder diffraction data. J Phys Chem B 109:7781-7787. (Pubitemid 40643997)
25. Teng J, Bates S, Engers DA, Leach K, Schields P, Yang Y. 2010. Effect of water-vapor sorption on local structure of polyvinylpyrrolidone. J Pharm Sci (accepted).
26. Jansen M, Schön JC, van Wüllen L. 2006. The route to the structure determination of amorphous solids: A case study of the ceramic Si3B3N7. Angew Chem, Int Ed Engl 45:4244-4263.
27. 2 structure. J Mater Sci 22:1374-1378.